ClouDx-I researchers published an article entitled “Big data, Hadoop and cloud computing in genomics” in the Journal of Biomedical informatics in July 2013.  http://www.sciencedirect.com/science/article/pii/S1532046413001007

Since then this article has been viewed 4960 times and is the fourth most downloaded article in this journal in the last 90 days (March 2014).


Below is the article dashboard showing details.

The biologists in the ClouDx-i team have extracted DNA from 11 samples.  10 samples were suitable for sequencing and one sample was degraded.  Nsilico have sent the good samples to EldaBiotech in Dublin for sequencing with results due sometime in April.

The samples were from the following species:

1. Strep agalactiae Group B
   
2. Enterococcus faecalis
   
3. Escherichia coli
   
4. Pantoea species
   
5. Staphylococcus aureus
   
6. Enterococcus faecalis
   
7. Staphylococcus aureus
   
8. Serratia marcescens
   

Synthetic biotech is evolutionizing and becoming an integral part of every major industry, including medicine, energy, agriculture and manufacturing.
http://synbioaxlr8r.com/future/

Paul joined some of the top experts in Synthetic Biology in one of Europes top biotech hubs, to meet and discuss that exciting future, as well as the steps and hurdles todays SynBio entrepreneurs, investors and researchers must face to get there.

 Dr Walsh presented progress on ClouDx-i and also sat on a panel for discussion and raised issues about the future of computational biology in clinical settings.